GE Healthcare to Partner with NIBRT for Biopharma Education Program
The companies plan to create a new curriculum focusing on single-use applications training, cell therapy technology, process efficiency strategies, process development methodologies, and chromatography proficiency.
GE Healthcare (GEHC) announced on Sept. 11, 2019 that it is teaming up with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.
The companies plan to share GEHC’s Fast Trak training and education curriculum and will co-develop a new curriculum to help the global biomanufacturing industry meet the needs of changing technologies and modalities,. The new curriculum will feature single-use applications training, cell-therapy technology, process efficiency strategies, process development methodologies, and chromatography proficiency.
“At NIBRT, we pride ourselves on our best-in-class education and training programs that support the thriving biopharmaceutical industry. By working with GEHC we will be able to leverage their biomanufacturing expertise to create exciting new programs designed to meet the global demand for talent,” said Killian O’Driscoll, director of projects, NIBRT, in the press release.
Courses will be available at the Jefferson Institute of Bioprocessing in Philadelphia, PA, the NIBRT facility in Dublin, and at GEHC Fast Trak locations in the United States, South Korea, Sweden, India, China, Turkey, Japan, and Singapore.
Source: GE Healthcare
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
